{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:35Z","timestamp":1790630435275,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Spark Holland B.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) are important biomarkers in research and diagnosis of growth disorders. Quantitative analysis is performed using various ligand-binding assays or enzymatic digestion LC-MS\/MS methods, whose widespread adoption is hampered by time-consuming sample preparation procedures. We present a simple and fast antibody-free LC-MS\/MS method for the quantification of intact IGF-1 and IGF-2 in human plasma. The method requires 50\u00a0\u03bcL of plasma and uses fully\n                    <jats:sup>15<\/jats:sup>\n                    N-labelled IGF-1 as internal standard. It features trifluoroethanol (TFE)-based IGF\/IGF-binding protein complex dissociation and a two-step selective protein precipitation workflow, using 5% acetic acid in 80\/20 acetone\/acetonitrile (precipitation 1) and ice-cold ethanol (precipitation 2). Detection of intact IGF-1 and IGF-2 is performed by means of a Waters XEVO TQ-S triple quadrupole mass spectrometer in positive electrospray ionisation (ESI+) mode. Lower limits of quantification were 5.9\u00a0ng\/mL for IGF-1 and 8.4\u00a0ng\/mL for IGF-2. Intra-assay imprecision was below 4.5% and inter-assay imprecision was below 5.8% for both analytes. An excellent correlation was found between nominal and measured concentrations of the WHO reference standard for IGF-1. Comparison with the IDS-iSYS IGF-1 immunoassay showed good correlation (\n                    <jats:italic>R<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009&gt;\u20090.97), although a significant bias was observed with the immunoassay giving substantially higher concentrations. The LC-MS\/MS method described here allows for reliable and simultaneous quantification of IGF-1 and IGF-2 in plasma, without the need for enzymatic digestion. The method can be readily implemented in clinical mass spectrometry laboratories and has the potential to be adapted for the analysis of different similarly sized peptide hormones.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00216-021-03185-y","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T05:58:16Z","timestamp":1613023096000},"page":"2035-2044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["An antibody-free LC-MS\/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma"],"prefix":"10.1007","volume":"413","author":[{"given":"Mark S.","family":"Pratt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"van Faassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Remmelts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"3185_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejogrb.2011.10.005","volume":"160","author":"C Demendi","year":"2012","unstructured":"Demendi C, B\u00f6rzs\u00f6nyi B, Nagy ZB, Rig\u00f3 J, Pajor A, Jo\u00f3 JG. Gene expression patterns of insulin-like growth factor 1, 2 (IGF-1, IGF-2) and insulin-like growth factor binding protein 3 (IGFBP-3) in human placenta from preterm deliveries: influence of additional factors. Eur J Obstet Gynecol Reprod Biol. 2012;160:40\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3185_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ymeth.2015.04.029","volume":"81","author":"H Ketha","year":"2015","unstructured":"Ketha H, Singh RJ. Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1). Methods. 2015;81:93\u20138.","journal-title":"Methods"},{"key":"3185_CR3","first-page":"45","volume":"21","author":"A Philippou","year":"2007","unstructured":"Philippou A, Maridaki M, Halapas A, Koutsilieris M. The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo. 2007;21:45\u201354.","journal-title":"In Vivo"},{"key":"3185_CR4","doi-asserted-by":"publisher","first-page":"e49884","DOI":"10.1371\/journal.pone.0049884","volume":"7","author":"H Cao","year":"2012","unstructured":"Cao H, Wang G, Meng L, Shen H, Feng Z, Liu Q, et al. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One. 2012;7:e49884.","journal-title":"PLoS One"},{"key":"3185_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1474-9726.2008.00417.x","volume":"7","author":"L Fontana","year":"2008","unstructured":"Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008;7:681\u20137.","journal-title":"Aging Cell"},{"key":"3185_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00018-004-4297-y","volume":"62","author":"M Katic","year":"2005","unstructured":"Katic M, Kahn CR. The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci. 2005;62:320\u201343.","journal-title":"Cell Mol Life Sci"},{"key":"3185_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1158\/1055-9965.EPI-07-2694","volume":"17","author":"MJ Borugian","year":"2008","unstructured":"Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, et al. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomark Prev. 2008;17:252\u20134.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3185_CR8","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1200\/JCO.2005.02.4828","volume":"23","author":"D Pink","year":"2005","unstructured":"Pink D, Schoeler D, Lindner T, Thuss-Patience PC, Kretzschmar A, Knipp H, et al. Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases. J Clin Oncol. 2005;23:6809\u201311.","journal-title":"J Clin Oncol"},{"key":"3185_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1530\/ERC-13-0231","volume":"20","author":"C Livingstone","year":"2013","unstructured":"Livingstone C. IGF2 and cancer. Endocr Relat Cancer. 2013;20:321\u201339.","journal-title":"Endocr Relat Cancer"},{"key":"3185_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11102-007-0032-z","volume":"10","author":"DR Clemmons","year":"2007","unstructured":"Clemmons DR. IGF-I assays: current assay methodologies and their limitations. Pituitary. 2007;10:121\u20138.","journal-title":"Pituitary"},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ghir.2009.09.004","volume":"20","author":"J Frystyk","year":"2010","unstructured":"Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays - a 2009 update. Growth Hormon IGF Res. 2010;20:8\u201318.","journal-title":"Growth Hormon IGF Res"},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1179\/acb.2006.053","volume":"61","author":"E Anckaert","year":"2006","unstructured":"Anckaert E, Schiettecatte J, Vanbesien J, Smitz J, Velkeniers B, De Schepper J. Variability among five different commercial IGF-1 immunoassays in conditions of childhood-onset GH deficiency and GH therapy. Acta Clin Belg. 2006;61:335\u20139.","journal-title":"Acta Clin Belg"},{"key":"3185_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2265.2007.03120.x","volume":"68","author":"ML Granada","year":"2008","unstructured":"Granada ML, Ulied A, Casanueva FF, Pico A, Lucas T, Torres E, et al. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clin Endocrinol. 2008;68:942\u201350.","journal-title":"Clin Endocrinol"},{"key":"3185_CR14","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1210\/jc.2016-1257","volume":"101","author":"P Chanson","year":"2016","unstructured":"Chanson P, Arnoux A, Mavromati M, Brailly-Tabard S, Massart C, Young J, et al. Reference values for IGF-I serum concentrations: comparison of six immunoassays. J Clin Endocrinol Metab. 2016;101:3450\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3185_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/rcm.3388","volume":"22","author":"M Bredeh\u00f6ft","year":"2008","unstructured":"Bredeh\u00f6ft M, Sch\u00e4nzer W, Thevis M. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography\/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:477\u201385.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3185_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ymeth.2011.08.009","volume":"56","author":"A Thomas","year":"2011","unstructured":"Thomas A, Sch\u00e4nzer W, Delahaut P, Thevis M. Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods. 2011;56:230\u20135.","journal-title":"Methods"},{"key":"3185_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0081125","volume":"8","author":"EE Niederkofler","year":"2013","unstructured":"Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, et al. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. PLoS One. 2013;8:1\u20136.","journal-title":"PLoS One"},{"key":"3185_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.chroma.2007.03.058","volume":"1153","author":"S Kirsch","year":"2007","unstructured":"Kirsch S, Widart J, Louette J, Focant JF, De Pauw E. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J Chromatogr A. 2007;1153:300\u20136.","journal-title":"J Chromatogr A"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/cen.12085","volume":"78","author":"R Kay","year":"2013","unstructured":"Kay R, Halsall DJ, Annamalai AK, Kandasamy N, Taylor K, Fenwick S, et al. A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly. Clin Endocrinol. 2013;78:424\u201330.","journal-title":"Clin Endocrinol"},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1373\/clinchem.2013.208538","volume":"60","author":"HD Cox","year":"2014","unstructured":"Cox HD, Lopes F, Woldemariam GA, Becker JO, Parkin MC, Thomas A, et al. Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. Clin Chem. 2014;60:541\u20138.","journal-title":"Clin Chem"},{"key":"3185_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jprot.2014.09.013","volume":"113","author":"G Such-Sanmart\u00edn","year":"2015","unstructured":"Such-Sanmart\u00edn G, Bache N, Callesen AK, Rogowska-Wrzesinska A, Jensen ON. Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation. J Proteome. 2015;113:29\u201337.","journal-title":"J Proteome"},{"key":"3185_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1515\/cclm-2017-1042","volume":"56","author":"KJ Bronsema","year":"2018","unstructured":"Bronsema KJ, Klont F, Schalk FB, Bischoff R, Kema IP, Van De Merbel NC. A quantitative LC-MS\/MS method for insulin-like growth factor 1 in human plasma. Clin Chem Lab Med. 2018;56:1905\u201312.","journal-title":"Clin Chem Lab Med"},{"key":"3185_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4155\/bio-2019-0234","volume":"12","author":"NN Tanna","year":"2020","unstructured":"Tanna NN, Lame ME, Wrona M. Development of an UPLC\/MS-MS method for quantification of intact IGF-I from human serum. Bioanalysis. 2020;12:53\u201365.","journal-title":"Bioanalysis"},{"key":"3185_CR24","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/rcm.6908","volume":"28","author":"F Lopes","year":"2014","unstructured":"Lopes F, Cowan DA, Thevis M, Thomas A, Parkin MC. Quantification of intact human insulin-like growth factor-I in serum by nano-ultrahigh-performance liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2014;28:1426\u201332.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3185_CR25","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1021\/pr100656u","volume":"9","author":"JL Proc","year":"2010","unstructured":"Proc JL, Kuzyk MA, Hardie DB, Yang J, Smith DS, Jackson AM, et al. A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin. J Proteome Res. 2010;9:5422\u201337.","journal-title":"J Proteome Res"},{"key":"3185_CR26","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1021\/ac201800g","volume":"83","author":"CE Bystrom","year":"2011","unstructured":"Bystrom CE, Sheng S, Clarke NJ. Narrow mass extraction of time-of-flight data for quantitative analysis of proteins: determination of insulin-like growth factor-1. Anal Chem. 2011;83:9005\u201310.","journal-title":"Anal Chem"},{"key":"3185_CR27","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1021\/acs.analchem.7b01125","volume":"89","author":"F Klont","year":"2017","unstructured":"Klont F, Ten Hacken NHT, Horvatovich P, Bakker SJL, Bischoff R. Assuring consistent performance of an insulin-like growth factor 1 MALDImmunoassay by monitoring measurement quality indicators. Anal Chem. 2017;89:6188\u201395.","journal-title":"Anal Chem"},{"key":"3185_CR28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1373\/clinchem.2014.234799","volume":"61","author":"J Hines","year":"2015","unstructured":"Hines J, Milosevic D, Ketha H, Taylor R, Algeciras-Schimnich A, Grebe SK, et al. Detection of IGF-1 protein variants by use of LC-MS with high-resolution accurate mass in routine clinical analysis. Clin Chem. 2015;61:990\u20131.","journal-title":"Clin Chem"},{"key":"3185_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0092801","volume":"9","author":"PE Oran","year":"2014","unstructured":"Oran PE, Trenchevska O, Nedelkov D, Borges CR, Schaab MR, Rehder DS, et al. Parallel workflow for high-throughput (>1,000 samples\/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay. PLoS One. 2014;9:1\u20138.","journal-title":"PLoS One"},{"key":"3185_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ghir.2009.02.002","volume":"19","author":"C Burns","year":"2009","unstructured":"Burns C, Rigsby P, Moore M, Rafferty B. The first international standard for insulin-like growth factor-1 (IGF-1) for immunoassay: preparation and calibration in an international collaborative study. Growth Hormon IGF Res. 2009;19:457\u201362.","journal-title":"Growth Hormon IGF Res"},{"key":"3185_CR31","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1021\/pr050160f","volume":"4","author":"H Wang","year":"2005","unstructured":"Wang H, Qian W-J, Mottaz HM, TRW C, Anderson DJ, Moore RJ, et al. Development and evaluation of a micro- and nanoscale proteomic sample preparation method. J Proteome Res. 2005;4:2397\u2013403.","journal-title":"J Proteome Res"},{"key":"3185_CR32","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1002\/rcm.4237","volume":"23","author":"RG Kay","year":"2009","unstructured":"Kay RG, Barton C, Velloso CP, Brown RP, Bartlett C, Blazevich AJ, et al. High-throughput ultra-high-performance liquid chromatography\/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich a-2- glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Commun Mass Spectrom. 2009;23:3173\u201382.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3185_CR33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ijbiomac.2011.11.005","volume":"50","author":"H Yoshikawa","year":"2012","unstructured":"Yoshikawa H, Hirano A, Arakawa T, Shiraki K. Mechanistic insights into protein precipitation by alcohol. Int J Biol Macromol. 2012;50:865\u201371.","journal-title":"Int J Biol Macromol"},{"key":"3185_CR34","first-page":"15189","volume-title":"Medical laboratories - requirements for quality and competence","author":"International Organisation for Standardization (ISO) Standard","year":"2012","unstructured":"International Organisation for Standardization (ISO) Standard. Medical laboratories - requirements for quality and competence. Geneva: ISO; 2012. p. 15189."},{"key":"3185_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jbbm.2007.05.009","volume":"70","author":"B Okutucu","year":"2007","unstructured":"Okutucu B, Din\u00e7er A, Habib \u00d6, Zihnioglu F. Comparison of five methods for determination of total plasma protein concentration. J Biochem Biophys Methods. 2007;70:709\u201311.","journal-title":"J Biochem Biophys Methods"},{"key":"3185_CR36","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, et al. Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab. 2014;99:1712\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"3185_CR37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X","volume":"13","author":"H Yu","year":"1999","unstructured":"Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, Van Doorn J, et al. Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin- like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal. 1999;13:166\u201372.","journal-title":"J Clin Lab Anal"}],"updated-by":[{"DOI":"10.1007\/s00216-021-03507-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000}}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-021-03185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-021-03185-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-021-03185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T22:03:27Z","timestamp":1626386607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-021-03185-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1007\/s00216-021-03185-y","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00216-021-03507-0","URL":"https:\/\/doi.org\/10.1007\/s00216-021-03507-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}